Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The coagulation factor synthesis pathway is a complex series of enzymatic reactions involving multiple proteins (coagulation factors) that ultimately lead to the formation of a stable blood clot. This pathway is essential for hemostasis, the process of stopping bleeding after vascular injury. The cascade is initiated by either the intrinsic or extrinsic pathway, converging on the common pathway, which culminates in the activation of thrombin and the subsequent conversion of fibrinogen to fibrin, the structural protein of the clot.
Various, including inhibition of specific coagulation factors (e.g., thrombin, factor Xa), vitamin K antagonism, or enhancement of antithrombin activity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation Factor Synthesis Pathway.